Vision Therapy in Practice: Finding the Line Between Appropriate Use and Overreach

Vision therapy has long occupied an interesting place in eye care. For some conditions, there is a growing body of research supporting its use. For others, questions remain about where appropriate treatment ends and overreach begins.

On the 4-Eyed Professor Podcast, Dr. Chris Lievens sits down with Dr. Marie Bodack, Chief of Pediatrics at Southern College of Optometry, to explore that line—and what optometrists should consider before incorporating vision therapy into patient care.

Where Vision Therapy Has Its Strongest Foundation

Not every application of vision therapy carries the same level of evidence. Convergence insufficiency remains one of the clearest examples, supported by research including the Convergence Insufficiency Treatment Trial.

Strabismus is another developing area, particularly exotropia, while the relationship between vision therapy and learning remains more debated. Brain injury and concussion care are also gaining attention as clinicians recognize binocular, accommodative, and eye movement problems following head trauma.

The important distinction is that vision therapy should begin with the patient’s diagnosis and symptoms—not simply with the availability of therapy.

How Long Should Vision Therapy Take?

For basic binocular problems, Bodack points to roughly three to four months as a reasonable framework, with research supporting approximately 12 weeks of weekly in-office therapy supplemented by home activities.

That timeline is not absolute. Patients respond differently, and adherence to home therapy varies. But when a straightforward convergence problem stretches into six or eight months without meaningful improvement, Bodack suggests clinicians should reconsider the diagnosis, treatment strategy, or whether another issue is contributing.

Recognizing When Treatment Becomes Overreach

The conversation becomes particularly important when therapy continues despite poor results.

Bodack recalls seeing children who had undergone years of vision therapy while still lacking an appropriate spectacle prescription or other fundamental treatment. For referring optometrists, this makes communication and follow-up essential.

Clinicians should understand what a referral practice is doing, expect communication about patient progress, and reconsider referrals when outcomes consistently fall short.

Vision therapy also does not need to become an all-or-nothing specialty. Primary care optometrists can begin with manageable cases such as convergence, accommodation, and eye movement disorders while referring more complex patients when appropriate.

Vision Therapy After Concussion

Post-concussion care demonstrates how individualized therapy can be. Patients may experience convergence problems, accommodative dysfunction, abnormal saccades, motion sensitivity, or photophobia.

Rather than treating every brain injury the same way, Bodack recommends starting with a detailed history and the patient’s specific symptoms. Management may include therapy, prism, tints, or other strategies designed to improve comfort and visual function.

Starting Vision Therapy Without Reinventing a Practice

For optometrists interested in offering vision therapy, the entry point does not have to involve expensive technology or an entirely new practice model.

Bodack’s advice is simple: start with education and straightforward cases. Refresh clinical knowledge, attend professional meetings, reconnect with professors and colleagues, and become comfortable identifying binocular and accommodative problems already walking through the practice.

Perhaps the most important lesson is knowing when not to treat. As Bodack explains through the example of baseball great Rickey Henderson, an observable binocular finding does not automatically mean it needs to be “fixed.” Symptoms, function, and the patient’s goals should guide the decision.

Vision therapy is ultimately another clinical tool—not a universal solution. Used thoughtfully, with evidence, appropriate patient selection, and measurable goals, it can expand what optometrists are able to offer while keeping patient outcomes at the center of care.

Christopher Lievens
Christopher Lievens
Chris Lievens is the Director of Research and Professor at Southern College of Optometry. Dr. Lievens has been employed in private practice, an ophthalmology referral center and he served in the United States Air Force. Dr. Lievens was the Chief of Aerospace Optometry at the Pentagon before joining SCO. Dr. Lievens is a fellow of the American Academy of Optometry and was the Region Chair of the Academy’s Admittance Committee. He is a distinguished fellow in the National Academies of Practice and a fellow in the British Contact Lens Association. Dr. Lievens is the co-creator of the fundus grading card and currently conducts research in glaucoma, dry eye, uveitis and contact lens care. Dr. Lievens has a Master’s degree in Healthcare Administration and a PhD from Anglia Ruskin University, Cambridge, UK. He is a member of the American Optometric Association, the British Contact Lens Association, the Association for Vision and Research in Ophthalmology and the Royal Society of Medicine. You can see Dr. Lievens on his monthly podcast on the Defocus Media host network called the 4eyedProfessor.

Get in Touch

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Latest Posts